Torax Medical, Inc. announced preliminary results from the CALIBER Trial that were presented at Digestive Disease Week (DDW) in Chicago, IL. The CALIBER Trial compared LINX®, a revolutionary solution for GERD, and omeprazole, an acid suppression medication (sold under the brand name Prilosec®) to determine which treatment was more effective for managing regurgitation.
http://www.prnewswire.com/news-releases/linx-more-effective-than-omeprazole-at-controlling-regurgitation-and-improving-quality-of-life-in-patients-with-gastroesophageal-reflux-disease-gerd-300463123.html
LINX® more effective than Omeprazole at controlling regurgitation and improving quality of life in patients with Gastroesophageal Reflux Disease (GERD)